Successful cell therapy begins with precise cell testing

In recent years, cell therapy has become a key development in regenerative medicine. However, not every patient is a candidate for the same type of cell therapy.

Treatment efficacy depends not only on cell quality but is also significantly influenced by factors such as the patient's immune status, the tumor microenvironment, and cell function.

Therefore, conducting a Precise Cell Assessment before starting treatment has increasingly become a vital foundation for improving success rates.

‍

What is Companion Diagnostics?

Companion Diagnostics uses biomarkers and cell function analysis to help physicians determine if a patient is suitable for a specific treatment, providing a more scientifically grounded strategy.

In the field of cell therapy, companion diagnostics is more than just a "pre-treatment check"—it is an essential decision-making tool for personalized medicine.

‍

Why is a Precise Cell Assessment necessary before cell therapy?

Every patient's immune system is unique.

Without a comprehensive cell assessment, even the same cell product can lead to vastly different treatment outcomes.

Precise cell testing helps medical teams gain a deep understanding of a patient's cellular status, serving as a critical basis for treatment planning, including:

• Whether immune function is normal
• Whether T cells are exhibiting exhaustion
• Whether the proportion of regulatory T cells (Tregs) is too high
• Whether there is immune suppression within the tumor microenvironment
• Stem cell activity and regenerative capacity
• Cell proliferation and repair potential

This information helps in formulating a personalized treatment strategy better suited to the patient.

‍